LifeStance Health Group, Inc. (LFST) Stock Overview
Explore LifeStance Health Group, Inc.’s financial performance, market position, analyst ratings, and future outlook.
LifeStance Health Group, Inc. (LFST)
Key Financials
Key Financials
Market Cap
4.8B
P/E Ratio
95.80
EPS (TTM)
$0.13
ROE
0.03%
LFST Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of LifeStance Health Group, Inc. (NASDAQ: LFST) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, LifeStance Health Group, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of LFST on the NASDAQ shows an RSI of 63.07, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $8.75 for the NASDAQ listing.
Key metrics behind LifeStance Health Group, Inc.'s NASDAQ-traded stock include a P/E ratio of 95.80 and a market capitalization of 4.8B. Combined with our AI analysis, these give both institutional and retail investors a clear view of LFST on the NASDAQ.